Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 34, Issue 3, 2002, Pages 394-397

  Berenguer, Juan ^a   Gonzaález, Juan ^b   Pulido, Federico ^c   Padilla, Beleén ^a   Casado, Joseé Luis ^d   Rubio, Rafael ^c   Arribas, Joseé Rarmoó n ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REMISSION; RETINITIS; VIRUS LOAD; VIRUS REACTIVATION; VISUAL IMPAIRMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOPREVENTION; COHORT STUDIES; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 0036467055     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338401     Document Type: Article

References (14)

1. Cytomegalovirus retinitis: New developments in prophylaxis and therapy
2. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
3. + T cell homeostasis and function in advanced HIV disease
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
5. + cell count: A randomized, double-blind, placebo-controlled trial
6. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection
7. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor b1
8. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
9. + counts
10. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy
11. Discontinuation of anti-cytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
12. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis
13. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy
14. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1